[Enhancement of LAK activity with recombinant gamma-IFN in patients with hepatocellular carcinoma].
D006528:Carcinoma, Hepatocellular / Q000276:immunology* / Q000628:therapy; D002478:Cells, Cultured; D006801:Humans; D007371:Interferon-gamma / Q000627:therapeutic use*; D007694:Killer Cells, Natural / Q000276:immunology*; D008113:Liver Neoplasms / Q000276:immunology* / Q000628:therapy
D007371:Interferon-gamma